Rob Breedlove

The number that matters is total marketing spend plus intake labor, divided by cases actually signed and appointed. Breedlove argues that a low per-lead price can hide a high cost per case when most leads were never SSDI-qualified or went cold before intake reached them, and that firms usually have never run the figure by source, so they cannot tell which channel is actually<｜begin▁of▁sentence｜>cheap.

Breedlove describes a managing partner who quoted an $18 lead cost as if it were a win.

• Run the arithmetic: if it takes 60 of those leads to sign one case, that case carries about $1,080 in acquisition spend before a single hour of intake time, while a $45 lead that converts at a much higher rate could sign cases at a third of that cost.
• Breedlove's suggested exercise is to pull the cases actually signed in the last 90 days, trace each back to its source, and divide total cost by cases signed rather than leads received.

Read original · Original 2

In SSDI, the attorney fee is capped at $9,200 or 25% of the claimant's back pay, whichever is smaller, so there is no large settlement at the end to cover a bloated acquisition cost. Breedlove says firms can absorb a sloppy cost per retained case in personal injury because the case ceiling is far away and invisible; in SSDI, the ceiling is close and fixed, so the firms that track cost per retained case by source tend to outgrow the ones chasing lead volume.

A managing partner Breedlove quotes signed 40 new cases in a quarter and was still staring at the profit-and-loss statement wondering where the money went. Breedlove pairs that with an average attorney fee on a won SSDI case of $3,750, per a national survey the post cites, which sits well under the $9,200 cap, and asks whether the firm's cost per retained case includes intake payroll or only ad spend, and whether it is known by source rather than blended.

Read original · Original 2 · Original 3

Return policies typically credit a wrong practice area, a duplicate submission, or a fake phone number, but not a real person in the right state who never intended to hire a lawyer and stopped answering, because that lead is judged technically valid.

• Breedlove frames the gap as structural rather than a vendor scandal: it explains why cost-per-lead keeps looking fine even as cost per signed case quietly climbs.
• The alternative Breedlove proposes is paying for cases already pre-appointed, with Form SSA-1696 filed, where a valid-but-going-nowhere lead is not a category that exists.

Breedlove recounts a firm that read its lead vendor's return policy aloud: wrong practice area gets a credit, duplicate submission gets a credit, fake number gets a credit, and a real, reachable, properly diagnosed claimant who went dark after the first call does not. The audit Breedlove suggests is to pull the last 90 days of lead credits next to the last 90 days of leads that simply never converted.

Read original · Original 2

A claimant who was not ready in March is not the same person in October, because denials get appealed, medical records catch up, and situations change. Breedlove treats redialing thousands of cold files as a systems problem rather than a staffing failure, since intake is busy with fresh leads and working an old list is not a fair ask of a representative, so reactivation needs its own campaign running separately from the active pipeline.

Breedlove runs the numbers on a 10,000-lead list bought at $10 to $25 per lead, meaning $100,000 to $250,000 already spent.

• Using the $3,750 average fee cited elsewhere, reactivating 5% yields 500 signed cases and roughly $1,875,000 in fees; 12% yields about $4,500,000; a 25,000-lead firm at 12% reaches about $11,250,000.
• Breedlove points to the AI-driven database reactivation system they say they built, which works old leads in the background and hands intake only conversations worth having, and argues that giving up a share of recovered revenue is a better deal than any other line in the marketing budget.

Read original

The improvised version is a memory exercise that stops scaling past roughly twenty open files, and the failure is structural rather than a matter of staff quality: a person juggling forty leads will eventually let one slip, while a system knows a retainer went out nine days ago unsigned and queues the next action. Breedlove's test is whether lead movement depends on one person's discipline, which makes that person a single point of failure sitting on top of every acquisition dollar.

Breedlove cites firms using a real CRM converting roughly 47% better than firms tracking by hand, against an industry average lead-to-signed conversion around 14% and top firms at 40% or higher, and says the firms at 40% keep working leads ten to fifteen days out across calls, texts, and email because the system tracks the touches. The two questions offered for a managing partner: how many follow-up attempts a lead actually gets and over what window, and whether an intake coordinator's open leads keep moving if that person goes on vacation tomorrow.

Read original

Each post opens with a specific scene or quoted conversation, makes a single number-driven argument, and closes by assigning a task for the week, such as pulling 90 days of lead credits or signed cases by source. Longer posts end with a direct-message invitation and a hashtag block, and two posts announce themselves as installments in a larger framework.

The openings are scenes rather than topic statements: a managing partner proudly quoting an $18 lead, another reading a vendor refund policy out loud, another signing 40 cases and wondering where the money went. The closing asks are consistently small and portable, for example dividing total cost by cases signed rather than leads received, or comparing 90 days of lead credits against 90 days of quiet non-conversions.

Read original · Original 2 · Original 3 · Original 4 · Original 5

Start here for the cost-per-signed-case framework.

Breedlove tells of a managing partner proud of an $18 lead cost, then shows why that number does not answer what it costs to sign a case.

• If it takes 60 leads to sign one case, that $18 lead costs $1,080 in acquisition spend before staff time; a $45 lead with much higher conversion can sign cases at a third of that cost.
• Breedlove repeats the SSDI constraint: average attorney fee around $3,750, capped at $9,200, with no personal-injury jackpot to cover a bloated acquisition cost.
• The action is to pull actual signed cases from the last 90 days, trace them to source, and divide total cost by cases signed, not leads received.

For brands planning a campaign

Co-marketing content can center on source-level cost-per-signed-case reporting, with a simple 90-day attribution exercise and a data-partnership offer around pay-for-filed cases.

Start here to understand that follow-up depends on a system, not individual discipline.

Breedlove contrasts hand tracking such as spreadsheets, sticky notes, and inbox follow-up folders with a CRM that automates cadence.

• They cite firms using a real CRM converting roughly 47% better than hand-tracking firms, an industry average lead-to-signed conversion around 14%, and strong firms at 40% or higher.
• The practical failure mode is a person juggling forty open leads who eventually lets one slip, while a CRM remembers a retainer sent nine days ago with no signature and queues the next action.
• Breedlove gives two audit questions: how many touches a lead gets and over what window, and whether an intake coordinator's open leads keep moving if that person goes on vacation.

For brands planning a campaign

A legal marketing technology partner can co-create an intake follow-up audit or CRM content series around the 14% versus 40% gap, with templates for touch cadence and vacation-proof lead ownership.

Start here to understand the fixed fee ceiling that makes every acquisition number matter.

Breedlove opens with a managing partner who signed 40 cases and still wondered where the money went.

• They explain that SSDI attorney fees are capped at $9,200 or 25% of back pay, whichever is smaller, unlike personal injury cases that can be worth far more.
• Breedlove pushes firms to track cost per retained case, meaning total marketing spend plus intake labor divided by signed retainers, not just cost per lead.
• They warn that a cost per retained case creeping toward $2,000 or $2,500 against a $9,200 ceiling changes the business.
• The post lists three questions: does the metric include intake payroll, do you know true cost per case by source, and would your best channel remain profitable if its cost doubled?

For brands planning a campaign

Content partnership can build an SSDI unit-economics calculator, a cost-per-retained-case worksheet, or a source-level cost-per-case briefing for law firm managing partners.

Start here to understand the refund-policy gap that distorts SSDI lead buying.

Breedlove reads a lead vendor return policy aloud: wrong practice area gets credit, duplicate submission gets credit, fake phone number gets credit, but a real person in the right state with the right diagnosis who never intended to hire a lawyer and went dark is 'technically valid,' so no credit.

• The distinction is between data validity, which the vendor sells, and case conversion, which the firm needs.
• Breedlove says the gap explains why cost per lead lies even when refund logs look clean.
• The proposed alternative is buying cases already pre-appointed with Form SSA-1696 filed, where 'technically valid but going nowhere' is not a category.
• They recommend pulling 90 days of lead credits against 90 days of leads that quietly never converted.

For brands planning a campaign

Co-marketing can create a valid-versus-convertible explainer, a lead-credit audit template, and comparison content on raw leads versus pre-appointed cases.

Start here to understand the reactivation opportunity before looking at acquisition tactics.

Breedlove frames old, unsold leads as an already-paid asset.

• A firm with 10,000 dead leads at $10 to $25 per lead has already spent $100,000 to $250,000 acquiring them.
• They cite an average attorney fee of $3,750 on a won SSDI case, below the $9,200 cap, then run reactivation math: 5% of 10,000 leads equals 500 cases and $1,875,000 in fees; 12% equals $4,500,000; a 25,000-lead firm at 12% reaches $11,250,000.
• Breedlove treats redialing old leads as a systems problem, not an intake-rep task, and describes an AI-driven database reactivation system that works old leads in the background and hands intake only worthwhile conversations.

For brands planning a campaign

A technology partner can co-produce reactivation ROI models, webinars, and case studies that show how AI-driven campaigns run separately from active intake.

One post opens with a managing partner proudly quoting $18 per lead; Breedlove works the number through: if it takes 60 of those leads to sign one case, acquisition spend on that case is $1,080 before a single hour of intake labor, while a $45 lead that converts far better might sign cases at a third of the cost.

• His fix is a measurement change, not a budget change — trace the cases actually signed in the last 90 days back to their source and divide total spend by cases signed rather than leads received.
• He expects most firms to find their "expensive" channel is the cheap one and their cheap channel is the most expensive thing they buy.

Opens with a quoted conversation, converts it into a single worked comparison, then gives one concrete task for the week.

For brands planning a campaign

A co-marketing partner selling intake or marketing analytics can build the same measurement change into joint content — defining cost per signed case by source — with Breedlove as the practitioner voice. His posts already close with a DM prompt, so the reply path a partnership would use is one he uses himself.

Examples: Source 1 · Source 2

He cites the cap of $9,200 or 25% of back pay, whichever is smaller, and a national survey putting the average fee on a won case at $3,750 — well under the ceiling.

• Because there is no large settlement at the end, unlike personal injury or mass tort, a rising cost per retained case cannot be absorbed later.
• He describes firms that signed 40 cases in a quarter and still could not account for the money, and asks whether cost per retained case includes intake payroll or only ad spend, and whether the firm knows that number by source rather than blended.

Contrast with personal injury economics, then three direct questions the reader can answer against their own numbers.

The fee cap and the average-fee figure are asserted in the posts without a linked source; they should be verified before being reused in partner content.

For brands planning a campaign

Content aimed at SSDI firms has to be built on practice-area economics rather than generic legal-marketing language. A technology partner can supply the by-source data and dashboards Breedlove says firms lack, which makes a joint piece complementary rather than duplicative.

Examples: Source 1 · Source 2 · Source 3

Breedlove argues the refund only ever covers a lead being wrong, never a lead being dead, and that most leads are in the second category. He contrasts paying for raw contact data with paying for cases that are already pre-appointed, with Form SSA-1696 filed, where the gap between valid and convertible disappears.

Quotes the policy back in plain terms, then reframes it as a structural product problem rather than a vendor scandal.

For brands planning a campaign

This is the sharpest split between Breedlove and a per-lead vendor, and it is also where he is selling: he states he generates SSDI cases nationwide on a filed-1696 fee basis. A co-marketing piece on vendor evaluation would need to be explicit about whose offer is featured and how the two are kept separate.

Examples: Source 1 · Source 2

Using the $3,750 average fee he cites, reactivating 5% of a 10,000-lead list yields 500 signed cases and roughly $1,875,000; at 12% the figure is about $4,500,000; a 25,000-lead firm at 12% reaches about $11,250,000.

• He argues the blocker is capacity, not willingness — intake is busy with fresh leads, and redialing cold files is not a fair ask of a representative — so reactivation needs its own campaign running monthly and again yearly, separate from the active pipeline.
• He points to the AI-driven database reactivation system he built and frames giving up a share of recovered revenue as a better deal than any other line in the marketing budget.

Sunk-cost framing plus arithmetic scaled to small, mid-size and large firms, so any reader can substitute their own list size.

For brands planning a campaign

This is Breedlove's most developed pitch and the one closest to the stated partnership brief on lead reactivation. Co-marketing content here would sit directly alongside a product claim he already makes; the arrangement needs a clear division between his offer and the partner's tooling.

Examples: Source 1

He says the systematized firms convert roughly 47% better, against an industry average around 14% lead-to-signed and top firms at 40% or more, and argues the improvised version fails past about twenty open files no matter how good the intake staff is.

• The firms at 40% keep working leads ten to fifteen days out across calls, texts and email because a system is tracking the touches.
• His two tests: how many follow-up attempts a lead actually gets and over what window, and whether open leads keep moving when an intake coordinator takes a vacation.

Names the failure mode as a process problem rather than a staffing problem, then gives two questions a managing partner can answer immediately.

The 47% and 14% conversion figures appear without a stated source, so they should be treated as his claims rather than market data until confirmed.

For brands planning a campaign

CRM-driven follow-up is the second half of the stated brief and the area where Breedlove's argument is least commercially loaded. A technology partner can co-produce a practical intake audit — cadence, touch counts, coverage during absence — using his framing and the partner's tooling.

Examples: Source 1

Each opens with a specific scene or quoted conversation — a managing partner reading a refund policy out loud, a partner quoting an $18 lead — then makes a single number-driven argument, then assigns a task for the week such as pulling 90 days of lead credits or signed cases by source.

• Longer posts close with a P.S. inviting direct messages and a hashtag block (#SSDI, #LawFirmGrowth, #LegalMarketing, #SocialSecurityDisability).
• Two posts announce themselves as installments, one as "the first piece of a bigger framework" and another promising "coming next in this series."

Serialized long-form text posts on LinkedIn, written for managing partners and intake directors, with the ask held to the closing lines.

For brands planning a campaign

A co-marketing series can slot into a format Breedlove already runs, but expect the partner's product to appear in the closing paragraph rather than the opening, and expect replies to arrive as direct messages rather than comments or clicks.

Examples: Source 1 · Source 2 · Source 3 · Source 4 · Source 5

Both treat attribution and follow-through as the real constraint on spending.

Works with restoration contractors rather than law firms, so the arguments carry no fixed fee cap and no legal-ethics framing. The diagnosis centres on owner belief and pipeline hygiene, with no SSDI case economics and no reactivation offer attached.

Read original · Original 2

Publishes mainly as an interviewer and curator of other operators' methods rather than first-person analysis, and covers family law, medical negligence and other practice areas rather than SSDI specifically. No product or service is being sold alongside the lessons.

Read original · Original 2

Both argue that how a firm buys and handles clients is the real strategic question, not how much it spends.

Practises personal injury in Georgia and writes about protecting client service from volume economics, so the subject is firm strategy and advocacy rather than SSDI lead economics. The tone is a warning about where the market is heading, and the posts carry no commercial offer.

Read original · Original 2

The two reviewed posts run the same structure Breedlove uses — close rate by rep, lead source by dollar, first response time — and push harder on why owners do not act on numbers they already have: one calls it a belief problem, the other an ego tax on decisions a owner refuses to revisit. A partner building content about intake speed, CRM hygiene, and attribution for trades businesses gets a voice whose examples match that business.

The tradeoff is industry fit.

• Restoration economics do not carry the SSDI constraints that shape Breedlove's arguments — a fixed attorney fee cap, claimant qualification, and vendor credit policies written for legal leads.
• The reviewed posts show no legal-marketing offer, no lead-reactivation product, and no law-firm intake examples, so the same brief would require adapting the argument rather than co-marketing it.
• A reader looking for SSDI-specific reactivation and CRM follow-up gets the general principle and none of the legal detail.

Examples: Source 1 · Source 2

The two reviewed posts are episode announcements featuring agency-side guests, one described as leading search, paid media, and revenue operations for legal professionals, the other working on Google and Meta ads plus intake optimisation for UK firms. For a joint interview series or guest-driven partnership where the technical partner supplies the substance, that host role and guest access fit the shape.

The tradeoff is that the reviewed posts show convening and framing, not a documented method.

• They promote episodes and credit the guests; neither contains lead-reactivation mechanics, CRM follow-up cadence, cost-per-signed-case reasoning, or SSDI intake detail presented as DeBettencourt's own position.
• A partner that needs the co-marketing content to carry the practical reactivation and follow-up arguments Breedlove's posts demonstrate would have to write them, and would lose Breedlove's own worked numbers and first-person firm examples.

Examples: Source 1 · Source 2

The two reviewed posts argue that private-equity-backed consolidation raises client acquisition costs and pushes firms toward more cases per lawyer, and advise small firms to compete on personal attention and service instead of ad spend. That pairs well with a campaign on plaintiff-firm positioning, attorney caseloads, or the service tradeoffs of consolidation.

The tradeoff is a different set of economics.

• Champion's argument rests on contingent personal-injury fees, where a single case can be worth tens or hundreds of thousands of dollars; Breedlove's rests on a fixed SSDI fee cap and the cost of acquiring and reactivating leads underneath it.
• Neither reviewed post covers lead reactivation, CRM follow-up, or claimant intake, and the audience is personal-injury attorneys rather than SSDI operators.
• Reusing this for the same brief would mean rebuilding the argument around a fee model the posts do not address.

Examples: Source 1 · Source 2